Literature DB >> 33719211

Cytotoxic effect of targeted biodegradable epothilone B and rapamycin co-loaded nanocarriers on breast cancer cells.

Alicja Zajdel1, Adam Wilczok1, Katarzyna Jelonek2, Anna Kaps1, Monika Musiał-Kulik2, Janusz Kasperczyk2.   

Abstract

The new therapeutic solutions for breast cancer treatment are needed, for example, combined therapy consisted of several drugs that characterize different mechanisms of action and modern drug delivery systems. Therefore, we used combination of epothilone B (EpoB) and rapamycin (Rap) to analyze the cytotoxic effect against breast cancer cells (MCF-7; MDA-MB-231). Also, the effect of drugs co-delivered in bioresorbable micelles functionalized with biotin (PLA-PEG-BIO; poly(lactide)-co-poly(ethylene glycol)-biotin) was studied. The comparison of effects of the mixture of free drugs and the micelles co-loaded with EpoB and Rap revealed a significant decrease in the cell metabolic activity and survival. Moreover, the dual drug-loaded PLA-PEG-BIO micelles enhanced the cytotoxicity of EpoB and Rap against the tested cells as compared with the free drugs. The blank PLA-PEG-BIO micelles did not affect the tested cells. We expect that mixture of EpoB and Rap may be promising in breast cancer treatment and PLA-PEG-BIO micelles as carrier of these two drugs can be applicable for successful targeted delivery.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  PLA-PEG-BIO micelles; breast cancer cells; cytotoxicity; epothilone B; rapamycin

Mesh:

Substances:

Year:  2021        PMID: 33719211     DOI: 10.1002/jbm.a.37164

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  1 in total

1.  Effect of MUC16 mutations on tumor mutation burden and its potential prognostic significance for cutaneous melanoma.

Authors:  Zi Wang; Huimin Hou; Haomin Zhang; Xingwu Duan; Lingling Li; Lingfeng Meng
Journal:  Am J Transl Res       Date:  2022-02-15       Impact factor: 4.060

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.